nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—ADRA1D—Amitriptyline—migraine	0.208	0.309	CbGbCtD
Phenylephrine—ADRA1B—Amitriptyline—migraine	0.151	0.225	CbGbCtD
Phenylephrine—ADRA1A—Amitriptyline—migraine	0.119	0.177	CbGbCtD
Phenylephrine—CYP1A2—Propranolol—migraine	0.0581	0.0864	CbGbCtD
Phenylephrine—CYP1A2—Amitriptyline—migraine	0.0503	0.0747	CbGbCtD
Phenylephrine—CYP1A2—Valproic Acid—migraine	0.0458	0.0681	CbGbCtD
Phenylephrine—CYP1A2—Verapamil—migraine	0.0399	0.0593	CbGbCtD
Phenylephrine—MAOA—locus ceruleus—migraine	0.00518	0.276	CbGeAlD
Phenylephrine—Tapentadol—HTR3A—migraine	0.0036	0.616	CrCbGaD
Phenylephrine—MAOA—nerve—migraine	0.00155	0.0825	CbGeAlD
Phenylephrine—Tapentadol—SLC6A4—migraine	0.00143	0.244	CrCbGaD
Phenylephrine—Acute coronary syndrome—Amitriptyline—migraine	0.00135	0.0073	CcSEcCtD
Phenylephrine—Myocardial infarction—Amitriptyline—migraine	0.00134	0.00726	CcSEcCtD
Phenylephrine—Atrioventricular block—Valproic Acid—migraine	0.00134	0.00725	CcSEcCtD
Phenylephrine—Neck pain—Valproic Acid—migraine	0.00132	0.00711	CcSEcCtD
Phenylephrine—Lacrimation increased—Timolol—migraine	0.00126	0.00679	CcSEcCtD
Phenylephrine—Photophobia—Valproic Acid—migraine	0.00122	0.0066	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Verapamil—migraine	0.00122	0.00657	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Gabapentin—migraine	0.00119	0.00645	CcSEcCtD
Phenylephrine—Atrioventricular block—Timolol—migraine	0.00119	0.00645	CcSEcCtD
Phenylephrine—Lacrimation increased—Gabapentin—migraine	0.00117	0.00632	CcSEcCtD
Phenylephrine—Blood pressure increased—Timolol—migraine	0.00116	0.00626	CcSEcCtD
Phenylephrine—Mydriasis—Topiramate—migraine	0.00114	0.00615	CcSEcCtD
Phenylephrine—Sweating increased—Verapamil—migraine	0.00112	0.00606	CcSEcCtD
Phenylephrine—Atrioventricular block—Gabapentin—migraine	0.00111	0.00601	CcSEcCtD
Phenylephrine—Arrhythmia—Amitriptyline—migraine	0.0011	0.00594	CcSEcCtD
Phenylephrine—Pallor—Topiramate—migraine	0.00109	0.00591	CcSEcCtD
Phenylephrine—Neck pain—Gabapentin—migraine	0.00109	0.0059	CcSEcCtD
Phenylephrine—Photophobia—Timolol—migraine	0.00109	0.00587	CcSEcCtD
Phenylephrine—Blood pressure increased—Gabapentin—migraine	0.00108	0.00583	CcSEcCtD
Phenylephrine—Dysgeusia—Amitriptyline—migraine	0.00105	0.00567	CcSEcCtD
Phenylephrine—Eye pain—Valproic Acid—migraine	0.00104	0.00565	CcSEcCtD
Phenylephrine—Pulmonary oedema—Timolol—migraine	0.00103	0.00557	CcSEcCtD
Phenylephrine—Skin exfoliation—Gabapentin—migraine	0.00103	0.00556	CcSEcCtD
Phenylephrine—Bradycardia—Propranolol—migraine	0.00102	0.00551	CcSEcCtD
Phenylephrine—Photophobia—Gabapentin—migraine	0.00101	0.00547	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Verapamil—migraine	0.00101	0.00547	CcSEcCtD
Phenylephrine—Vision blurred—Amitriptyline—migraine	0.00101	0.00545	CcSEcCtD
Phenylephrine—Myocardial infarction—Verapamil—migraine	0.00101	0.00544	CcSEcCtD
Phenylephrine—Tremor—Amitriptyline—migraine	0.001	0.00542	CcSEcCtD
Phenylephrine—Lacrimation increased—Topiramate—migraine	0.000983	0.00532	CcSEcCtD
Phenylephrine—Agitation—Amitriptyline—migraine	0.000983	0.00532	CcSEcCtD
Phenylephrine—Visual impairment—Propranolol—migraine	0.000964	0.00521	CcSEcCtD
Phenylephrine—Syncope—Amitriptyline—migraine	0.000959	0.00519	CcSEcCtD
Phenylephrine—Pulmonary oedema—Gabapentin—migraine	0.000959	0.00519	CcSEcCtD
Phenylephrine—Palpitations—Amitriptyline—migraine	0.000945	0.00511	CcSEcCtD
Phenylephrine—Loss of consciousness—Amitriptyline—migraine	0.00094	0.00508	CcSEcCtD
Phenylephrine—Bradycardia—Verapamil—migraine	0.000937	0.00507	CcSEcCtD
Phenylephrine—Atrioventricular block—Topiramate—migraine	0.000934	0.00505	CcSEcCtD
Phenylephrine—Eye pain—Timolol—migraine	0.00093	0.00503	CcSEcCtD
Phenylephrine—Cardiac disorder—Propranolol—migraine	0.000929	0.00502	CcSEcCtD
Phenylephrine—Hypertension—Amitriptyline—migraine	0.000924	0.00499	CcSEcCtD
Phenylephrine—Visual impairment—Verapamil—migraine	0.000887	0.0048	CcSEcCtD
Phenylephrine—Visual disturbance—Timolol—migraine	0.000886	0.00479	CcSEcCtD
Phenylephrine—Mental disorder—Propranolol—migraine	0.000877	0.00474	CcSEcCtD
Phenylephrine—MAOA—neck—migraine	0.00087	0.0464	CbGeAlD
Phenylephrine—Eye pain—Gabapentin—migraine	0.000866	0.00468	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Valproic Acid—migraine	0.000862	0.00466	CcSEcCtD
Phenylephrine—Abdominal pain upper—Valproic Acid—migraine	0.000862	0.00466	CcSEcCtD
Phenylephrine—Shock—Amitriptyline—migraine	0.000859	0.00465	CcSEcCtD
Phenylephrine—Tachycardia—Amitriptyline—migraine	0.000852	0.00461	CcSEcCtD
Phenylephrine—Photophobia—Topiramate—migraine	0.000851	0.0046	CcSEcCtD
Phenylephrine—Hyperhidrosis—Amitriptyline—migraine	0.000844	0.00456	CcSEcCtD
Phenylephrine—Epinephrine—TNF—migraine	0.000816	0.14	CrCbGaD
Phenylephrine—Agitation—Propranolol—migraine	0.0008	0.00433	CcSEcCtD
Phenylephrine—Sweating increased—Valproic Acid—migraine	0.000794	0.0043	CcSEcCtD
Phenylephrine—Paraesthesia—Amitriptyline—migraine	0.000784	0.00424	CcSEcCtD
Phenylephrine—Abdominal pain upper—Timolol—migraine	0.000767	0.00415	CcSEcCtD
Phenylephrine—Vision blurred—Verapamil—migraine	0.000755	0.00408	CcSEcCtD
Phenylephrine—MAOA—trigeminal ganglion—migraine	0.000752	0.04	CbGeAlD
Phenylephrine—Tremor—Verapamil—migraine	0.000751	0.00406	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000736	0.00398	CcSEcCtD
Phenylephrine—Agitation—Verapamil—migraine	0.000736	0.00398	CcSEcCtD
Phenylephrine—Eye pain—Topiramate—migraine	0.000729	0.00394	CcSEcCtD
Phenylephrine—Syncope—Verapamil—migraine	0.000719	0.00389	CcSEcCtD
Phenylephrine—Palpitations—Verapamil—migraine	0.000708	0.00383	CcSEcCtD
Phenylephrine—Loss of consciousness—Verapamil—migraine	0.000704	0.00381	CcSEcCtD
Phenylephrine—Nervous system disorder—Propranolol—migraine	0.000697	0.00377	CcSEcCtD
Phenylephrine—Visual disturbance—Topiramate—migraine	0.000694	0.00375	CcSEcCtD
Phenylephrine—Urticaria—Amitriptyline—migraine	0.000694	0.00375	CcSEcCtD
Phenylephrine—Hypertension—Verapamil—migraine	0.000692	0.00374	CcSEcCtD
Phenylephrine—Skin disorder—Propranolol—migraine	0.00069	0.00373	CcSEcCtD
Phenylephrine—Chest pain—Verapamil—migraine	0.000682	0.00369	CcSEcCtD
Phenylephrine—ADRA1A—brainstem—migraine	0.000671	0.0357	CbGeAlD
Phenylephrine—MAOA—brainstem—migraine	0.000665	0.0354	CbGeAlD
Phenylephrine—Bradycardia—Valproic Acid—migraine	0.000664	0.00359	CcSEcCtD
Phenylephrine—ADRA1B—head—migraine	0.00066	0.0352	CbGeAlD
Phenylephrine—Sweating increased—Gabapentin—migraine	0.000658	0.00356	CcSEcCtD
Phenylephrine—ADRA1D—head—migraine	0.000646	0.0344	CbGeAlD
Phenylephrine—Shock—Verapamil—migraine	0.000643	0.00348	CcSEcCtD
Phenylephrine—Paraesthesia—Propranolol—migraine	0.000638	0.00345	CcSEcCtD
Phenylephrine—Tachycardia—Verapamil—migraine	0.000638	0.00345	CcSEcCtD
Phenylephrine—Dyspnoea—Propranolol—migraine	0.000634	0.00343	CcSEcCtD
Phenylephrine—Hyperhidrosis—Verapamil—migraine	0.000632	0.00342	CcSEcCtD
Phenylephrine—Visual impairment—Valproic Acid—migraine	0.000629	0.0034	CcSEcCtD
Phenylephrine—ADRA1B—nervous system—migraine	0.000626	0.0333	CbGeAlD
Phenylephrine—Pruritus—Amitriptyline—migraine	0.000618	0.00334	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Propranolol—migraine	0.000614	0.00332	CcSEcCtD
Phenylephrine—ADRA1D—nervous system—migraine	0.000612	0.0326	CbGeAlD
Phenylephrine—Pain—Propranolol—migraine	0.000608	0.00329	CcSEcCtD
Phenylephrine—ADRA1B—central nervous system—migraine	0.000603	0.0321	CbGeAlD
Phenylephrine—Abdominal pain upper—Topiramate—migraine	0.000601	0.00325	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Topiramate—migraine	0.000601	0.00325	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Gabapentin—migraine	0.000594	0.00321	CcSEcCtD
Phenylephrine—Angiopathy—Valproic Acid—migraine	0.000592	0.0032	CcSEcCtD
Phenylephrine—Bradycardia—Timolol—migraine	0.000591	0.0032	CcSEcCtD
Phenylephrine—Myocardial infarction—Gabapentin—migraine	0.000591	0.00319	CcSEcCtD
Phenylephrine—Immune system disorder—Valproic Acid—migraine	0.000589	0.00319	CcSEcCtD
Phenylephrine—ADRA1D—central nervous system—migraine	0.000589	0.0314	CbGeAlD
Phenylephrine—Mediastinal disorder—Valproic Acid—migraine	0.000588	0.00318	CcSEcCtD
Phenylephrine—Paraesthesia—Verapamil—migraine	0.000587	0.00318	CcSEcCtD
Phenylephrine—Arrhythmia—Valproic Acid—migraine	0.000583	0.00315	CcSEcCtD
Phenylephrine—Dyspnoea—Verapamil—migraine	0.000583	0.00315	CcSEcCtD
Phenylephrine—Dizziness—Amitriptyline—migraine	0.000577	0.00312	CcSEcCtD
Phenylephrine—Mental disorder—Valproic Acid—migraine	0.000572	0.00309	CcSEcCtD
Phenylephrine—Urticaria—Propranolol—migraine	0.000565	0.00305	CcSEcCtD
Phenylephrine—Visual impairment—Timolol—migraine	0.00056	0.00303	CcSEcCtD
Phenylephrine—Pain—Verapamil—migraine	0.000559	0.00302	CcSEcCtD
Phenylephrine—Tension—Valproic Acid—migraine	0.000557	0.00301	CcSEcCtD
Phenylephrine—Dysgeusia—Valproic Acid—migraine	0.000556	0.00301	CcSEcCtD
Phenylephrine—Vomiting—Amitriptyline—migraine	0.000555	0.003	CcSEcCtD
Phenylephrine—Sweating increased—Topiramate—migraine	0.000554	0.003	CcSEcCtD
Phenylephrine—Nervousness—Valproic Acid—migraine	0.000552	0.00298	CcSEcCtD
Phenylephrine—Bradycardia—Gabapentin—migraine	0.000551	0.00298	CcSEcCtD
Phenylephrine—Rash—Amitriptyline—migraine	0.00055	0.00298	CcSEcCtD
Phenylephrine—Dermatitis—Amitriptyline—migraine	0.00055	0.00297	CcSEcCtD
Phenylephrine—ADRA1A—cardiovascular system—migraine	0.000548	0.0292	CbGeAlD
Phenylephrine—Headache—Amitriptyline—migraine	0.000547	0.00296	CcSEcCtD
Phenylephrine—MAOA—cardiovascular system—migraine	0.000543	0.0289	CbGeAlD
Phenylephrine—Cardiac disorder—Timolol—migraine	0.000539	0.00292	CcSEcCtD
Phenylephrine—Vision blurred—Valproic Acid—migraine	0.000535	0.0029	CcSEcCtD
Phenylephrine—Tremor—Valproic Acid—migraine	0.000532	0.00288	CcSEcCtD
Phenylephrine—Angiopathy—Timolol—migraine	0.000527	0.00285	CcSEcCtD
Phenylephrine—Immune system disorder—Timolol—migraine	0.000525	0.00284	CcSEcCtD
Phenylephrine—Hypersensitivity—Propranolol—migraine	0.000524	0.00283	CcSEcCtD
Phenylephrine—Mediastinal disorder—Timolol—migraine	0.000524	0.00283	CcSEcCtD
Phenylephrine—Agitation—Valproic Acid—migraine	0.000522	0.00282	CcSEcCtD
Phenylephrine—Visual impairment—Gabapentin—migraine	0.000521	0.00282	CcSEcCtD
Phenylephrine—Urticaria—Verapamil—migraine	0.000519	0.00281	CcSEcCtD
Phenylephrine—Arrhythmia—Timolol—migraine	0.000519	0.00281	CcSEcCtD
Phenylephrine—Nausea—Amitriptyline—migraine	0.000519	0.0028	CcSEcCtD
Phenylephrine—Mental disorder—Timolol—migraine	0.000509	0.00275	CcSEcCtD
Phenylephrine—Cardiac disorder—Gabapentin—migraine	0.000502	0.00272	CcSEcCtD
Phenylephrine—Palpitations—Valproic Acid—migraine	0.000502	0.00272	CcSEcCtD
Phenylephrine—Tension—Timolol—migraine	0.000496	0.00268	CcSEcCtD
Phenylephrine—Dysgeusia—Timolol—migraine	0.000495	0.00268	CcSEcCtD
Phenylephrine—Nervousness—Timolol—migraine	0.000491	0.00266	CcSEcCtD
Phenylephrine—Hypertension—Valproic Acid—migraine	0.00049	0.00265	CcSEcCtD
Phenylephrine—Immune system disorder—Gabapentin—migraine	0.000489	0.00264	CcSEcCtD
Phenylephrine—Mediastinal disorder—Gabapentin—migraine	0.000488	0.00264	CcSEcCtD
Phenylephrine—Chest pain—Valproic Acid—migraine	0.000484	0.00262	CcSEcCtD
Phenylephrine—Hypersensitivity—Verapamil—migraine	0.000482	0.00261	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00048	0.0026	CcSEcCtD
Phenylephrine—ADRA1B—brain—migraine	0.000478	0.0255	CbGeAlD
Phenylephrine—Vision blurred—Timolol—migraine	0.000477	0.00258	CcSEcCtD
Phenylephrine—Mental disorder—Gabapentin—migraine	0.000474	0.00256	CcSEcCtD
Phenylephrine—Dizziness—Propranolol—migraine	0.00047	0.00254	CcSEcCtD
Phenylephrine—ADRA1D—brain—migraine	0.000468	0.0249	CbGeAlD
Phenylephrine—Bradycardia—Topiramate—migraine	0.000463	0.00251	CcSEcCtD
Phenylephrine—Pruritus—Verapamil—migraine	0.000463	0.0025	CcSEcCtD
Phenylephrine—Tension—Gabapentin—migraine	0.000462	0.0025	CcSEcCtD
Phenylephrine—Dysgeusia—Gabapentin—migraine	0.000461	0.00249	CcSEcCtD
Phenylephrine—Nervousness—Gabapentin—migraine	0.000457	0.00247	CcSEcCtD
Phenylephrine—Nervous system disorder—Valproic Acid—migraine	0.000455	0.00246	CcSEcCtD
Phenylephrine—Syncope—Timolol—migraine	0.000454	0.00245	CcSEcCtD
Phenylephrine—Tachycardia—Valproic Acid—migraine	0.000452	0.00245	CcSEcCtD
Phenylephrine—Vomiting—Propranolol—migraine	0.000452	0.00244	CcSEcCtD
Phenylephrine—Skin disorder—Valproic Acid—migraine	0.00045	0.00244	CcSEcCtD
Phenylephrine—Hyperhidrosis—Valproic Acid—migraine	0.000448	0.00242	CcSEcCtD
Phenylephrine—Rash—Propranolol—migraine	0.000448	0.00242	CcSEcCtD
Phenylephrine—Dermatitis—Propranolol—migraine	0.000448	0.00242	CcSEcCtD
Phenylephrine—Palpitations—Timolol—migraine	0.000447	0.00242	CcSEcCtD
Phenylephrine—Loss of consciousness—Timolol—migraine	0.000444	0.0024	CcSEcCtD
Phenylephrine—Vision blurred—Gabapentin—migraine	0.000444	0.0024	CcSEcCtD
Phenylephrine—Tremor—Gabapentin—migraine	0.000441	0.00239	CcSEcCtD
Phenylephrine—Visual impairment—Topiramate—migraine	0.000439	0.00237	CcSEcCtD
Phenylephrine—Hypertension—Timolol—migraine	0.000437	0.00236	CcSEcCtD
Phenylephrine—Agitation—Gabapentin—migraine	0.000433	0.00234	CcSEcCtD
Phenylephrine—Dizziness—Verapamil—migraine	0.000432	0.00234	CcSEcCtD
Phenylephrine—Chest pain—Timolol—migraine	0.000431	0.00233	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000428	0.00231	CcSEcCtD
Phenylephrine—Cardiac disorder—Topiramate—migraine	0.000422	0.00228	CcSEcCtD
Phenylephrine—Syncope—Gabapentin—migraine	0.000422	0.00228	CcSEcCtD
Phenylephrine—Nausea—Propranolol—migraine	0.000422	0.00228	CcSEcCtD
Phenylephrine—Paraesthesia—Valproic Acid—migraine	0.000416	0.00225	CcSEcCtD
Phenylephrine—Palpitations—Gabapentin—migraine	0.000416	0.00225	CcSEcCtD
Phenylephrine—Vomiting—Verapamil—migraine	0.000416	0.00225	CcSEcCtD
Phenylephrine—Loss of consciousness—Gabapentin—migraine	0.000414	0.00224	CcSEcCtD
Phenylephrine—Dyspnoea—Valproic Acid—migraine	0.000413	0.00224	CcSEcCtD
Phenylephrine—Angiopathy—Topiramate—migraine	0.000413	0.00223	CcSEcCtD
Phenylephrine—Rash—Verapamil—migraine	0.000412	0.00223	CcSEcCtD
Phenylephrine—Dermatitis—Verapamil—migraine	0.000412	0.00223	CcSEcCtD
Phenylephrine—Immune system disorder—Topiramate—migraine	0.000411	0.00222	CcSEcCtD
Phenylephrine—Mediastinal disorder—Topiramate—migraine	0.00041	0.00222	CcSEcCtD
Phenylephrine—Headache—Verapamil—migraine	0.00041	0.00222	CcSEcCtD
Phenylephrine—Hypertension—Gabapentin—migraine	0.000407	0.0022	CcSEcCtD
Phenylephrine—Shock—Timolol—migraine	0.000406	0.0022	CcSEcCtD
Phenylephrine—Nervous system disorder—Timolol—migraine	0.000405	0.00219	CcSEcCtD
Phenylephrine—Chest pain—Gabapentin—migraine	0.000401	0.00217	CcSEcCtD
Phenylephrine—Skin disorder—Timolol—migraine	0.000401	0.00217	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Valproic Acid—migraine	0.0004	0.00216	CcSEcCtD
Phenylephrine—Hyperhidrosis—Timolol—migraine	0.000399	0.00216	CcSEcCtD
Phenylephrine—Mental disorder—Topiramate—migraine	0.000399	0.00216	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000398	0.00215	CcSEcCtD
Phenylephrine—Pain—Valproic Acid—migraine	0.000396	0.00214	CcSEcCtD
Phenylephrine—Tension—Topiramate—migraine	0.000389	0.0021	CcSEcCtD
Phenylephrine—Nausea—Verapamil—migraine	0.000388	0.0021	CcSEcCtD
Phenylephrine—Dysgeusia—Topiramate—migraine	0.000388	0.0021	CcSEcCtD
Phenylephrine—Nervousness—Topiramate—migraine	0.000385	0.00208	CcSEcCtD
Phenylephrine—Shock—Gabapentin—migraine	0.000378	0.00205	CcSEcCtD
Phenylephrine—Nervous system disorder—Gabapentin—migraine	0.000377	0.00204	CcSEcCtD
Phenylephrine—Tachycardia—Gabapentin—migraine	0.000375	0.00203	CcSEcCtD
Phenylephrine—Vision blurred—Topiramate—migraine	0.000373	0.00202	CcSEcCtD
Phenylephrine—Skin disorder—Gabapentin—migraine	0.000373	0.00202	CcSEcCtD
Phenylephrine—Hyperhidrosis—Gabapentin—migraine	0.000372	0.00201	CcSEcCtD
Phenylephrine—Tremor—Topiramate—migraine	0.000371	0.00201	CcSEcCtD
Phenylephrine—ADRA1A—head—migraine	0.000371	0.0198	CbGeAlD
Phenylephrine—Paraesthesia—Timolol—migraine	0.000371	0.002	CcSEcCtD
Phenylephrine—Urticaria—Valproic Acid—migraine	0.000368	0.00199	CcSEcCtD
Phenylephrine—Dyspnoea—Timolol—migraine	0.000368	0.00199	CcSEcCtD
Phenylephrine—MAOA—head—migraine	0.000368	0.0196	CbGeAlD
Phenylephrine—Agitation—Topiramate—migraine	0.000364	0.00197	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Timolol—migraine	0.000356	0.00193	CcSEcCtD
Phenylephrine—Syncope—Topiramate—migraine	0.000355	0.00192	CcSEcCtD
Phenylephrine—Pain—Timolol—migraine	0.000353	0.00191	CcSEcCtD
Phenylephrine—ADRA1A—nervous system—migraine	0.000352	0.0187	CbGeAlD
Phenylephrine—Palpitations—Topiramate—migraine	0.00035	0.00189	CcSEcCtD
Phenylephrine—MAOA—nervous system—migraine	0.000348	0.0186	CbGeAlD
Phenylephrine—Loss of consciousness—Topiramate—migraine	0.000348	0.00188	CcSEcCtD
Phenylephrine—Paraesthesia—Gabapentin—migraine	0.000345	0.00187	CcSEcCtD
Phenylephrine—Dyspnoea—Gabapentin—migraine	0.000343	0.00185	CcSEcCtD
Phenylephrine—Hypertension—Topiramate—migraine	0.000342	0.00185	CcSEcCtD
Phenylephrine—Hypersensitivity—Valproic Acid—migraine	0.000342	0.00185	CcSEcCtD
Phenylephrine—ADRA1A—central nervous system—migraine	0.000339	0.018	CbGeAlD
Phenylephrine—Chest pain—Topiramate—migraine	0.000337	0.00182	CcSEcCtD
Phenylephrine—MAOA—central nervous system—migraine	0.000336	0.0179	CbGeAlD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000335	0.00181	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Gabapentin—migraine	0.000332	0.00179	CcSEcCtD
Phenylephrine—ADRA1A—cerebellum—migraine	0.000331	0.0176	CbGeAlD
Phenylephrine—Pain—Gabapentin—migraine	0.000329	0.00178	CcSEcCtD
Phenylephrine—Pruritus—Valproic Acid—migraine	0.000328	0.00177	CcSEcCtD
Phenylephrine—MAOA—cerebellum—migraine	0.000328	0.0175	CbGeAlD
Phenylephrine—Urticaria—Timolol—migraine	0.000328	0.00177	CcSEcCtD
Phenylephrine—Shock—Topiramate—migraine	0.000318	0.00172	CcSEcCtD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000318	0.0027	CbGpPWpGaD
Phenylephrine—Nervous system disorder—Topiramate—migraine	0.000317	0.00172	CcSEcCtD
Phenylephrine—ADRA1A—GPCR ligand binding—RAMP1—migraine	0.000316	0.00269	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CALCRL—migraine	0.000316	0.00269	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000316	0.00269	CbGpPWpGaD
Phenylephrine—Tachycardia—Topiramate—migraine	0.000316	0.00171	CcSEcCtD
Phenylephrine—Skin disorder—Topiramate—migraine	0.000314	0.0017	CcSEcCtD
Phenylephrine—Hyperhidrosis—Topiramate—migraine	0.000313	0.00169	CcSEcCtD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR1D—migraine	0.000312	0.00265	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000311	0.00265	CbGpPWpGaD
Phenylephrine—Dizziness—Valproic Acid—migraine	0.000307	0.00166	CcSEcCtD
Phenylephrine—Urticaria—Gabapentin—migraine	0.000305	0.00165	CcSEcCtD
Phenylephrine—Hypersensitivity—Timolol—migraine	0.000304	0.00164	CcSEcCtD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000303	0.00258	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000302	0.00257	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—BDNF—migraine	0.0003	0.00255	CbGpPWpGaD
Phenylephrine—Vomiting—Valproic Acid—migraine	0.000295	0.00159	CcSEcCtD
Phenylephrine—ADRA1B—G alpha (q) signalling events—TAC1—migraine	0.000295	0.00251	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—NPS—migraine	0.000295	0.00251	CbGpPWpGaD
Phenylephrine—Rash—Valproic Acid—migraine	0.000292	0.00158	CcSEcCtD
Phenylephrine—Dermatitis—Valproic Acid—migraine	0.000292	0.00158	CcSEcCtD
Phenylephrine—Pruritus—Timolol—migraine	0.000292	0.00158	CcSEcCtD
Phenylephrine—Headache—Valproic Acid—migraine	0.00029	0.00157	CcSEcCtD
Phenylephrine—Paraesthesia—Topiramate—migraine	0.00029	0.00157	CcSEcCtD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2B—migraine	0.00029	0.00247	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00029	0.00247	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HTR2C—migraine	0.000289	0.00246	CbGpPWpGaD
Phenylephrine—Dyspnoea—Topiramate—migraine	0.000288	0.00156	CcSEcCtD
Phenylephrine—Hypersensitivity—Gabapentin—migraine	0.000283	0.00153	CcSEcCtD
Phenylephrine—ADRA1B—G alpha (q) signalling events—EDNRA—migraine	0.000281	0.00239	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000281	0.00239	CbGpPWpGaD
Phenylephrine—Gastrointestinal disorder—Topiramate—migraine	0.000279	0.00151	CcSEcCtD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000279	0.00237	CbGpPWpGaD
Phenylephrine—Pain—Topiramate—migraine	0.000277	0.0015	CcSEcCtD
Phenylephrine—Nausea—Valproic Acid—migraine	0.000275	0.00149	CcSEcCtD
Phenylephrine—Dizziness—Timolol—migraine	0.000273	0.00148	CcSEcCtD
Phenylephrine—Pruritus—Gabapentin—migraine	0.000272	0.00147	CcSEcCtD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000269	0.00229	CbGpPWpGaD
Phenylephrine—ADRA1A—brain—migraine	0.000269	0.0143	CbGeAlD
Phenylephrine—MAOA—brain—migraine	0.000266	0.0142	CbGeAlD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000264	0.00224	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000264	0.00224	CbGpPWpGaD
Phenylephrine—Vomiting—Timolol—migraine	0.000262	0.00142	CcSEcCtD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000262	0.00223	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—TAC1—migraine	0.000262	0.00223	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—NPS—migraine	0.000262	0.00223	CbGpPWpGaD
Phenylephrine—Rash—Timolol—migraine	0.00026	0.00141	CcSEcCtD
Phenylephrine—Dermatitis—Timolol—migraine	0.00026	0.00141	CcSEcCtD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR1D—migraine	0.000259	0.0022	CbGpPWpGaD
Phenylephrine—Headache—Timolol—migraine	0.000259	0.0014	CcSEcCtD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000258	0.0022	CbGpPWpGaD
Phenylephrine—Urticaria—Topiramate—migraine	0.000257	0.00139	CcSEcCtD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HTR2C—migraine	0.000257	0.00219	CbGpPWpGaD
Phenylephrine—Dizziness—Gabapentin—migraine	0.000254	0.00137	CcSEcCtD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—HTR2A—migraine	0.000253	0.00216	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000251	0.00214	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—EDNRA—migraine	0.00025	0.00213	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000248	0.00211	CbGpPWpGaD
Phenylephrine—Nausea—Timolol—migraine	0.000245	0.00133	CcSEcCtD
Phenylephrine—Vomiting—Gabapentin—migraine	0.000244	0.00132	CcSEcCtD
Phenylephrine—ADRA1D—GPCR downstream signaling—CALCRL—migraine	0.000242	0.00206	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—RAMP1—migraine	0.000242	0.00206	CbGpPWpGaD
Phenylephrine—Rash—Gabapentin—migraine	0.000242	0.00131	CcSEcCtD
Phenylephrine—Dermatitis—Gabapentin—migraine	0.000242	0.00131	CcSEcCtD
Phenylephrine—Headache—Gabapentin—migraine	0.000241	0.0013	CcSEcCtD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2B—migraine	0.000241	0.00205	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00024	0.00205	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000239	0.00203	CbGpPWpGaD
Phenylephrine—Hypersensitivity—Topiramate—migraine	0.000238	0.00129	CcSEcCtD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000236	0.00201	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000235	0.002	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000235	0.002	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000234	0.00199	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000234	0.00199	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000231	0.00197	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000231	0.00196	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR1D—migraine	0.00023	0.00196	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00023	0.00195	CbGpPWpGaD
Phenylephrine—Pruritus—Topiramate—migraine	0.000229	0.00124	CcSEcCtD
Phenylephrine—Nausea—Gabapentin—migraine	0.000228	0.00123	CcSEcCtD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000224	0.00191	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000223	0.0019	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000223	0.0019	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CALCRL—migraine	0.00022	0.00188	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—RAMP1—migraine	0.00022	0.00188	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.00022	0.00187	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000217	0.00185	CbGpPWpGaD
Phenylephrine—Dizziness—Topiramate—migraine	0.000214	0.00116	CcSEcCtD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2B—migraine	0.000214	0.00182	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HTR2A—migraine	0.000214	0.00182	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000213	0.00182	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000206	0.00175	CbGpPWpGaD
Phenylephrine—Vomiting—Topiramate—migraine	0.000206	0.00111	CcSEcCtD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000205	0.00175	CbGpPWpGaD
Phenylephrine—Rash—Topiramate—migraine	0.000204	0.0011	CcSEcCtD
Phenylephrine—Dermatitis—Topiramate—migraine	0.000204	0.0011	CcSEcCtD
Phenylephrine—Headache—Topiramate—migraine	0.000203	0.0011	CcSEcCtD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000202	0.00172	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CALCRL—migraine	0.000201	0.00171	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—RAMP1—migraine	0.000201	0.00171	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000198	0.00169	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000198	0.00169	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000196	0.00167	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000195	0.00166	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000195	0.00166	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000193	0.00164	CbGpPWpGaD
Phenylephrine—Nausea—Topiramate—migraine	0.000192	0.00104	CcSEcCtD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000191	0.00163	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000191	0.00163	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR1B—migraine	0.000189	0.00161	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000186	0.00159	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000183	0.00156	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CALCRL—migraine	0.000183	0.00156	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—RAMP1—migraine	0.000183	0.00156	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR1A—migraine	0.000182	0.00155	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—NPS—migraine	0.000179	0.00152	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—TAC1—migraine	0.000179	0.00152	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—RAMP1—migraine	0.000179	0.00152	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CALCRL—migraine	0.000179	0.00152	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HTR2A—migraine	0.000177	0.00151	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR1D—migraine	0.000176	0.0015	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000176	0.0015	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2C—migraine	0.000176	0.0015	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000174	0.00148	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000173	0.00148	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000173	0.00148	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—EDNRA—migraine	0.000171	0.00145	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00017	0.00145	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000168	0.00143	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000165	0.00141	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000165	0.00141	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—CALCA—migraine	0.000164	0.0014	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2B—migraine	0.000164	0.00139	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RAMP1—migraine	0.000162	0.00138	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CALCRL—migraine	0.000162	0.00138	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR1D—migraine	0.00016	0.00136	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000159	0.00135	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HTR2A—migraine	0.000157	0.00134	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR1B—migraine	0.000157	0.00133	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR7—migraine	0.000154	0.00131	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR1A—migraine	0.000151	0.00128	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000149	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2B—migraine	0.000149	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—TAC1—migraine	0.000149	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—NPS—migraine	0.000149	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR1D—migraine	0.000146	0.00125	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2C—migraine	0.000146	0.00124	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—EDNRA—migraine	0.000142	0.00121	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000141	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000141	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR1B—migraine	0.000139	0.00119	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000137	0.00117	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CALCA—migraine	0.000136	0.00116	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2B—migraine	0.000136	0.00116	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR1A—migraine	0.000134	0.00114	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR1D—migraine	0.000133	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—NPS—migraine	0.000132	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—TAC1—migraine	0.000132	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RAMP1—migraine	0.00013	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CALCRL—migraine	0.00013	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR1D—migraine	0.00013	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2C—migraine	0.000129	0.0011	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR7—migraine	0.000128	0.00109	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—EDNRA—migraine	0.000126	0.00107	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2B—migraine	0.000123	0.00105	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000122	0.00104	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CALCA—migraine	0.000121	0.00103	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CACNA1A—migraine	0.000121	0.00103	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2B—migraine	0.000121	0.00103	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR1D—migraine	0.000118	0.001	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000117	0.001	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR7—migraine	0.000113	0.000966	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2B—migraine	0.00011	0.000934	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—TNF—migraine	0.000109	0.000927	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RAMP1—migraine	0.000108	0.000919	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CALCRL—migraine	0.000108	0.000919	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2A—migraine	0.000108	0.000917	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR1B—migraine	0.000107	0.000909	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000107	0.000908	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	0.000107	0.000908	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000104	0.000888	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR1A—migraine	0.000103	0.000875	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—TAC1—migraine	0.000101	0.000862	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—NPS—migraine	0.000101	0.000862	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2C—migraine	9.92e-05	0.000845	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR1B—migraine	9.69e-05	0.000825	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—EDNRA—migraine	9.65e-05	0.000822	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RAMP1—migraine	9.59e-05	0.000817	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CALCRL—migraine	9.59e-05	0.000817	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR1D—migraine	9.45e-05	0.000805	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR1A—migraine	9.33e-05	0.000795	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CALCA—migraine	9.29e-05	0.000791	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—TAC1—migraine	9.19e-05	0.000782	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—NPS—migraine	9.19e-05	0.000782	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2C—migraine	9.01e-05	0.000767	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2A—migraine	8.94e-05	0.000761	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR1B—migraine	8.86e-05	0.000754	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2B—migraine	8.79e-05	0.000748	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EDNRA—migraine	8.77e-05	0.000746	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR7—migraine	8.69e-05	0.00074	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR1A—migraine	8.53e-05	0.000726	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CALCA—migraine	8.44e-05	0.000719	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—TAC1—migraine	8.4e-05	0.000715	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—NPS—migraine	8.4e-05	0.000715	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2C—migraine	8.24e-05	0.000701	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR1B—migraine	8.05e-05	0.000685	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—EDNRA—migraine	8.01e-05	0.000682	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2A—migraine	7.94e-05	0.000676	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR7—migraine	7.89e-05	0.000672	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR1B—migraine	7.87e-05	0.00067	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR1D—migraine	7.84e-05	0.000668	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR1A—migraine	7.74e-05	0.000659	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LRP1—migraine	7.74e-05	0.000659	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CALCA—migraine	7.71e-05	0.000657	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—TAC1—migraine	7.63e-05	0.000649	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—NPS—migraine	7.63e-05	0.000649	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR1A—migraine	7.57e-05	0.000645	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2C—migraine	7.48e-05	0.000637	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—NPS—migraine	7.46e-05	0.000635	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—TAC1—migraine	7.46e-05	0.000635	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2C—migraine	7.32e-05	0.000623	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2B—migraine	7.29e-05	0.000621	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EDNRA—migraine	7.28e-05	0.00062	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR7—migraine	7.21e-05	0.000614	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR1B—migraine	7.15e-05	0.000609	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—EDNRA—migraine	7.12e-05	0.000606	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CALCA—migraine	7e-05	0.000596	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR1D—migraine	6.97e-05	0.000593	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR1A—migraine	6.88e-05	0.000586	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CALCA—migraine	6.85e-05	0.000583	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—TAC1—migraine	6.77e-05	0.000577	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—NPS—migraine	6.77e-05	0.000577	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2C—migraine	6.64e-05	0.000566	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR7—migraine	6.55e-05	0.000558	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2B—migraine	6.48e-05	0.000552	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EDNRA—migraine	6.46e-05	0.00055	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LRP1—migraine	6.42e-05	0.000547	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR7—migraine	6.41e-05	0.000546	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CALCA—migraine	6.22e-05	0.00053	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2A—migraine	6.09e-05	0.000518	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH4—migraine	5.94e-05	0.000505	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR7—migraine	5.82e-05	0.000495	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR1B—migraine	5.73e-05	0.000488	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LRP1—migraine	5.7e-05	0.000486	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2A—migraine	5.53e-05	0.000471	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR1A—migraine	5.51e-05	0.000469	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PGR—migraine	5.43e-05	0.000462	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NPS—migraine	5.43e-05	0.000462	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TAC1—migraine	5.43e-05	0.000462	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2C—migraine	5.32e-05	0.000453	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EDNRA—migraine	5.18e-05	0.000441	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2A—migraine	5.05e-05	0.00043	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH3—migraine	5.05e-05	0.00043	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CALCA—migraine	4.98e-05	0.000424	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH4—migraine	4.93e-05	0.000419	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR1B—migraine	4.75e-05	0.000405	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR7—migraine	4.66e-05	0.000397	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2A—migraine	4.59e-05	0.000391	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR1A—migraine	4.57e-05	0.00039	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TAC1—migraine	4.51e-05	0.000384	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PGR—migraine	4.51e-05	0.000384	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NPS—migraine	4.51e-05	0.000384	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2A—migraine	4.49e-05	0.000382	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CACNA1A—migraine	4.46e-05	0.00038	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2C—migraine	4.42e-05	0.000376	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH4—migraine	4.38e-05	0.000373	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EDNRA—migraine	4.3e-05	0.000366	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR1B—migraine	4.22e-05	0.000359	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH3—migraine	4.19e-05	0.000357	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CALCA—migraine	4.14e-05	0.000352	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2A—migraine	4.08e-05	0.000347	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR1A—migraine	4.06e-05	0.000346	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFBR2—migraine	4.02e-05	0.000342	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TAC1—migraine	4e-05	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NPS—migraine	4e-05	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PGR—migraine	4e-05	0.000341	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MTHFR—migraine	4e-05	0.00034	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2C—migraine	3.92e-05	0.000334	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR7—migraine	3.87e-05	0.00033	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EDNRA—migraine	3.82e-05	0.000325	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH3—migraine	3.72e-05	0.000317	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CALCA—migraine	3.67e-05	0.000313	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR7—migraine	3.44e-05	0.000293	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFBR2—migraine	3.33e-05	0.000284	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—migraine	3.27e-05	0.000278	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFBR2—migraine	2.96e-05	0.000252	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ESR1—migraine	2.9e-05	0.000247	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—migraine	2.71e-05	0.000231	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—migraine	2.41e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—migraine	2.41e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—migraine	2.14e-05	0.000182	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—migraine	1.47e-05	0.000126	CbGpPWpGaD
